Information  X 
Enter a valid email address

Evgen Pharma PLC Ord 0.25P (EVG)

Date Time Source Announcement
05 Sep 2019 7:00 am
RNS
Agreement for supply of SFX-01 for autism trial
28 Aug 2019 7:00 am
RNS
Update on SAS study
07 Aug 2019 7:00 am
RNS
Grant of further European patent
05 Aug 2019 7:00 am
RNS
Research collaboration
25 Jul 2019 1:00 pm
RNS
Grant of Options
18 Jul 2019 3:47 pm
RNS
Result of AGM
  7:00 am
RNS
AGM Statement
24 Jun 2019 7:00 am
RNS
SFX-01 featured in SAH review paper
19 Jun 2019 10:39 am
RNS
Posting of Annual Report and AGM Notice
13 Jun 2019 7:00 am
RNS
Full Year Results
11 Jun 2019 7:00 am
RNS
Notification of Preliminary Results
22 May 2019 1:32 pm
RNS
Holding(s) in Company
21 May 2019 7:00 am
RNS
Share Option Exercise and Issue of Equity
09 May 2019 5:49 pm
RNS
Holding(s) in Company
  10:11 am
RNS
Holding(s) in Company
08 May 2019 11:29 am
RNS
Result of GM and Completion of Placing
26 Apr 2019 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
24 Apr 2019 11:37 am
RNS
Holding(s) in Company
  11:33 am
RNS
Holding(s) in Company
23 Apr 2019 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  10:30 am
RNS
Holding(s) in Company
18 Apr 2019 5:30 pm
RNS
Posting of Circular and Timing of General Meeting
17 Apr 2019 1:00 pm
RNS
Placing and Notice of General Meeting
02 Apr 2019 9:00 am
RNS
finnCap publishes initiation research
28 Mar 2019 7:00 am
RNS
Poster presentation of Imperial College data
25 Mar 2019 7:00 am
RNS
SFX-01 meets primary endpoints in STEM trial
18 Mar 2019 2:01 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Update on SFX-01 trial read-out dates
05 Mar 2019 7:00 am
RNS
SFX-01 data published in peer reviewed journal
06 Feb 2019 3:30 pm
RNS
Holding(s) in Company
05 Feb 2019 7:00 am
RNS
Clinical trial update confirms read-outs on track
30 Jan 2019 5:28 pm
RNS
Grant of Options
23 Jan 2019 7:00 am
RNS
SFX-01 featured in Nature Reviews Drug Discovery
22 Jan 2019 7:00 am
RNS
Change of Adviser
19 Dec 2018 6:02 pm
RNS
Share option exercise and issue of equity
12 Dec 2018 7:00 am
RNS
Interim Results
10 Dec 2018 3:00 pm
RNS
Nominated Adviser Status
04 Dec 2018 7:00 am
RNS
Poster Presentation of SFX-01 and Trial Update
03 Dec 2018 7:00 am
RNS
Notification of Half Year Results
19 Nov 2018 7:00 am
RNS
Investor Presentation in Manchester
08 Nov 2018 7:00 am
RNS
Directorate Changes
23 Oct 2018 9:57 am
RNS
Holding(s) in Company
18 Oct 2018 7:00 am
RNS
Placing
18 Sep 2018 7:00 am
RNS
Investor Symposium
11 Sep 2018 7:00 am
RNS
Notice of Investor Symposium
26 Jul 2018 3:22 pm
RNS
Result of AGM
  7:00 am
RNS
AGM Statement
25 Jul 2018 7:00 am
RNS
Final Patient Recruited in STEM Phase IIa Trial
10 Jul 2018 11:00 am
RNS
Grant of share options, issue of equity and TVR
29 Jun 2018 10:45 am
EQS
Evgen Pharma (EVG): 2018, a pivotal year
21 Jun 2018 12:30 pm
RNS
Posting of Annual Report and AGM Notice
13 Jun 2018 2:14 pm
EQS
Evgen Pharma (EVG): Encouraging interim data from the STEM trial
  7:00 am
RNS
Full Year Results
11 Jun 2018 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Interim Update on STEM Trial
07 Jun 2018 4:40 pm
RNS
Second Price Monitoring Extn
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t